Citius Oncology, Inc. CTOR Income before provision for income taxes
Income before provision for income taxes at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s income before provision for income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s income before provision for income taxes?
- Citius Oncology, Inc. (CTOR) reported income before provision for income taxes of -$26.84M in Q1 2026.
- How has Citius Oncology, Inc.'s income before provision for income taxes changed year-over-year?
- Citius Oncology, Inc.'s income before provision for income taxes decreased by 259.3% year-over-year, from -$7.47M to -$26.84M.
- What is the long-term trend for Citius Oncology, Inc.'s income before provision for income taxes?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s income before provision for income taxes has grown at a 39.8% compound annual growth rate (CAGR), from -$12.12M to -$23.7M.
- What does income before provision for income taxes mean?
- Indicates the total profitability of the business before the impact of income tax provisions. It is a key figure for evaluating the company's pre-tax earnings power and the underlying health of its ongoing business segments.